Expression of CD44v6 and livin in gastric cancer tissue

Chinese Medical Journal

Volumn 125, Issue 17, 2012, Pages 3161-3165

  Liang, Yi zhi ^a   Fang, Tai yong ^a   Xu, Hai gang ^a   Zhuo, Zhi qiang ^b  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b Quanzhou Children's Hospital   (China)

Author keywords

CD44v6; Expression; Gastric cancer; Immunohistochemistry; Livin

Indexed keywords

CD44V6 ANTIGEN; LIVIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; FEMALE; GASTRITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH POLYP; TUMOR DIFFERENTIATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; ANTIGENS, CD44; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; STOMACH NEOPLASMS;

EID: 84866072023     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.17.035     Document Type: Article

References (15)

1. Köbel M, Weichert W, Crüwell K, Schmitt WD, Lautenschläger C, Hauptmann S. Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis. Virchows Arch 2004; 445: 456-464.
2. Nachmias B, Ashhab Y, Bucholtz V, Drize O, Kadouri L, Lotem M, et al. Caspase-mediated cleavage coi1vcrts Hvin from an anfiapoptotic to a proapo ptotie factor: implications for drugresistant melanoma. Cancer Res 2003; 63: 6340-6349.
3. Ashhab Y, Alian A, Polliack A, Panet A, Ben Yehuda D. Two splicing variants ofanew inhibitor of apoptosis gene with diferent biological properties and tissue distribution pattern. FEBS Lett 2001; 495: 56-60.
4. Orian-Rousseau V, Morrison H, Matzke A, Kastilan T, Pace G, Herrlich P, et al. Hepatocyte growth actor-induced Ras activation requires ERM p roteins linked to both CD44v6 and F-actin. Mol Biol Cell 2007; 18: 76-83.
5. Li GS, Yao HT, Wang SQ. The relationship between the expression of CD44v6, vascular endothelial growth factor-C and lymphnode metastasis of gastric cancer. Chin J Clin Drug Res (Chin) 2005; 137: 14797-14798.
6. Carvalho R, Milne AN, Polak M, Offerhaus GJ, Weterman MA. A novel region of amplification at 1lp12-13 in gastric ancer. revealed by representational diference analysis, is associated with overexpression of CD44v6, especially in early-onset gastric carcinomas. Genes Chromosomes Cancer 2006; 45: 967-975.
7. Gu HP, Shang PZ. Expression and correlation of biotin and CD44v6 protein in gastric cancer. J Xi'an Jiaotong Univ (Med Ed) (Chin) 2007; 28: 415-417.
8. Diaz LK, Zhou X, Wright ET, Cristofanilli M, Smith T, Yang Y, et al. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma. Clin Cancer Res 2005; 11: 3309-3314.
9. Yu P, Zhou L, Ke W, Li K. Clinical significance of pAKT and CD44v6 overexpression with breast cancer. J Cancer Res Clin Oncol 2010; 136: 1283-1292.
10. Lin JH, Deng G, Huang Q, Morser J. KIAP, a novel member of the inhibitor of apoptosis protein family. Biochem Biophys Res Commun 2000; 279: 820-831.
11. Ka H, Hunt JS. Temporal and spetial patterns of expression of inhibitors of apoptosis in human placentas. Am J Patho1 2003; 163: 413-422.
12. Abd-Elrahman I, Hershko K, Neuman T, Nachmias B, Perlman R, Ben-Yehuda D. The inhibitor of ap optosis protein Livin (ML-IAP) plays a dual role in tumorigeni city. Cancer Res 2009; 69: 5475-5480.
13. Yagihashi A, Asanuma K, Kobayashi D, Tsuji N, Shijubo Y, Abe S, et al. Detection of autoantibodies to livin and survivin in sera from lung cancer patients. Lung Cancer 2005; 48: 217-221.
14. Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS, Dixit VM. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol 2000; 10: 1359-1366.
15. Crnković-Mertens I, Bulkescher J, Mensger C, Hoppe-Seyler F, Hoppe-Seyler K. Isolation of peptides blocking the function of antiapoptotic Livin protein. Cell Mol Life Sci 2010; 67: 1895-1905.